Postabaltive Pericarditis in Patient with a Prior History of Rheumatic Disease: a Case Report

Abstract

A 60 year-old male with a previous (40 years ago) history of rheumatic carditis without valve involvement and 5 years history of paroxysmal atrial fibrillation underwent ablation (PV isolation with roof and mitral isthmus lines). The following day patient developed AF episode with severe mid-sternal chest pain with widespread concave ST elevation throughout most of the limb leads (I, II, III, aVL, aVF) and precordial leads (V2-6). Serum troponin I was 87.2 ng/ml with a creatinine concentration of 0.88 mg/dl and hemoglobin level of 15 g/dl. 2D transthoracic echocardiogram excluded wall motion abnormalities, or significant pericardial effusions. Recurrence of acute rheumatic fever was excluded based on revised Jones criteria. Careful analysis of ECG allowed us to recognize the ECG criteria of pericarditis and to avoid unnecessary emergent coronary angiography. Ultimately, the patient was diagnosed with pericarditis. After diagnosis, the patient’s presenting symptoms resolved with treatment including sotalol 160 mg per day, nonsteroidal anti-inflammatory agents.

Conclusions: This is the first reported case study of post-cardiac ablation pericarditis in patient with prior history of rheumatic carditis.

Keywords

Postabaltive Pericarditis / paroxysmal atrial fibrillation / ablation / сomplications of ablation

References

[1] Hakalahti A, Biancari F, Nielsen JC, Raatikainen MJ. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Europace. 2015;17(3):370–378. DOI: 10.1093/europace/euu376

[2] Hakalahti A., Biancari F., Nielsen J.C., Raatikainen M.J. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis // Europace. 2015. Vol. 17, No. 3. P. 370–378. DOI: 10.1093/europace/euu376

[3] Arbelo E, Brugada J, Blomstrom-Lundqvist C, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38(17):1303–1306. DOI: 10.1093/eurheartj/ehw564

[4] Arbelo E., Brugada J., Blomstrom-Lundqvist C. et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry // Eur. Heart J. 2017. Vol. 38, No. 17. P. 1303–1306. DOI: 10.1093/eurheartj/ehw564

[5] Miyazaki S, Tada H. Complications of cryoballoon pulmonary vein isolation. Arrhythm Electrophysiol Rev. 2019;8(1):60–64. DOI: 10.15420/aer.2018.72.2

[6] Miyazaki S., Tada H. Complications of cryoballoon pulmonary vein isolation // Arrhythm. Electrophysiol. Rev. 2019. Vol. 8, No. 1. P. 60–64. DOI: 10.15420/aer.2018.72.2

[7] Schmidt M, Dorwarth U, Andresen D, et al. German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation-One-year outcome data. Heart Rhythm. 2016;13(4): 836–844. DOI: 10.1016/j.hrthm.2015.12.007

[8] Schmidt M., Dorwarth U., Andresen D. et al. German ablation registry: Cryoballoon vs. radiofrequency ablation in paroxysmal atrial fibrillation One-year outcome data // Heart Rhythm. 2016. Vol. 13, No. 4. P. 836–844. DOI: 10.1016/j.hrthm.2015.12.007

[9] Orme J, Eddin M, Loli A. regional pericarditis status post cardiac ablation: a case report. N Am J Med Sci. 2014;6(9):481–483. DOI: 10.4103/1947-2714.141653

[10] Orme J., Eddin M., Loli A. regional pericarditis status post cardiac ablation: a case report // N. Am. J. Med. Sci. 2014. Vol. 6, No. 9. P. 481–483. DOI: 10.4103/1947-2714.141653

[11] Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–38. DOI: 10.1161/CIRCEP.109.859116

[12] Cappato R., Calkins H., Chen S.A. et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation // Circ. Arrhythm. Electrophysiol. 2010. Vol. 3, No. 1. P. 32–38. DOI: 10.1161/CIRCEP.109.859116

[13] Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–1274. DOI: 10.1001/jama.2019.0693

[14] Packer D.L., Mark D.B., Robb R.A. et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. The CABANA Randomized Clinical Trial // JAMA. 2019. Vol. 321, No. 13. P. 1261–1274. DOI: 10.1001/jama.2019.0693

[15] Luckie M, Jenkins N, Davidson NC, Chauhan A. Dressler’s syndrome following pulmonary vein isolation for atrial fibrillation. Acute Card Care. 2008;10(4):234–235. DOI: 10.1080/17482940701843722

[16] Luckie M., Jenkins N., Davidson N.C., Chauhan A. Dressler’s syndrome following pulmonary vein isolation for atrial fibrillation // Acute Card. Care. 2008. Vol. 10, No. 4. P. 234–235. DOI: 10.1080/17482940701843722

[17] Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004;363(9410):717–727. DOI: 10.1016/S0140-6736(04)15648-1

[18] Troughton R.W., Asher C.R., Klein A.L. Pericarditis // Lancet. 2004. Vol. 363, No. 9410. P. 717–727. DOI: 10.1016/S0140-6736(04)15648-1

[19] Surawicz B, Lasseter KC. Electrocardiogram in pericarditis. Am J Cardiol. 1970;26(5):471–474. DOI: 10.1016/0002-9149(70)90704-6

[20] Surawicz B., Lasseter K.C. Electrocardiogram in pericarditis // Am. J. Cardiol. 1970. Vol. 26, No. 5. P. 471–474. DOI: 10.1016/0002-9149(70)90704-6

[21] Spodick DH. Diagnostic electrocardiographic sequences in acute pericarditis: Significance of PR segment and PR vector changes. Circulation. 1973;48(3):575–580. DOI: 10.1161/01.cir.48.3.575

[22] Spodick D.H. Diagnostic electrocardiographic sequences in acute pericarditis: Significance of PR segment and PR vector changes // Circulation. 1973. Vol. 48, No. 3. P. 575–580. DOI: 10.1161/01.cir.48.3.575

RIGHTS & PERMISSIONS

Zhelyakov E.G., Ardashev A.V., Kocharian A.A., Ginsburg M.L., Daniels E.